Skip to main content

Table 1 Demographic and clinical characteristics of the studied groups

From: Comparison of luteal phase stimulation with follicular phase stimulation in poor ovarian response: a single-blinded randomized controlled trial

Variable

LPOS, N = 31

FPOS, N = 33

P value

Age (year)

37 (26–39)

38 (30–39)

0.86

BMI

26 (21.4–34)

25 (20-26.2)

0.2

FSH (Day 3) (mIU/ml)

9 (3–16)

9 (3–19)

0.80

AMH (ng/ml)

0.5 (0.1–1.3)

0.9 (0.2–1.5)

0.037*

AFC

3 (1–5)

3 (2–5)

0.762

Gravidity

0 (0)

0 (0–2)

0.92

Parity

0 (0–1)

0 (0–1)

0.088

Number of gonadotropin ampoule (75 IU) (previous cycle)

67.3 (35–120)

61.7 (30–104)

0.23

Days of gonadotropin administration (previous cycle)

9.18 (5–12)

9.32 (6–14)

0.76

Number of previous IVF failure

1 (1–6)

1 (1–3)

0.362

  1. AFC Antral Follicle Count, AMH Anti-Mullerian hormone, BMI Body mass index, FPOS follicular phase ovarian stimulation, FSH Follicle Stimulating Hormone, MI Metaphase-I, MII Metaphase-II, LPOS Luteal-phase ovarian stimulation. The results were shown as median and range
  2. * Significant
  3. *P-value < 0.05